Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
AIDS Behav ; 19(7): 1327-37, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25626889

RESUMO

We describe the sexual behaviors of women at elevated risk of HIV acquisition who reside in areas of high HIV prevalence and poverty in the US. Participants in HPTN 064, a prospective HIV incidence study, provided information about individual sexual behaviors and male sexual partners in the past 6 months at baseline, 6- and 12-months. Independent predictors of consistent or increased temporal patterns for three high-risk sexual behaviors were assessed separately: exchange sex, unprotected anal intercourse (UAI) and concurrent partnerships. The baseline prevalence of each behavior was >30 % among the 2,099 participants, 88 % reported partner(s) with >1 HIV risk characteristic and both individual and partner risk characteristics decreased over time. Less than high school education and food insecurity predicted consistent/increased engagement in exchange sex and UAI, and partner's concurrency predicted participant concurrency. Our results demonstrate how interpersonal and social factors may influence sustained high-risk behavior by individuals and suggest that further study of the economic issues related to HIV risk could inform future prevention interventions.


Assuntos
Infecções por HIV/transmissão , Assunção de Riscos , Comportamento Sexual , Parceiros Sexuais , Adolescente , Adulto , Preservativos/estatística & dados numéricos , Feminino , Seguimentos , Abastecimento de Alimentos , Infecções por HIV/epidemiologia , Infecções por HIV/prevenção & controle , Humanos , Análise Multivariada , Prevalência , Estudos Prospectivos , Fatores de Risco , Fatores Socioeconômicos , Estados Unidos/epidemiologia , Adulto Jovem
2.
J Acquir Immune Defic Syndr ; 21(3): 228-35, 1999 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-10421247

RESUMO

To determine adherence by health care providers to guidelines for antiretroviral therapy and for prevention of opportunistic infections (OIs) in adults with HIV infection in federally funded facilities in the United States, we reviewed records of HIV-infected adults (>13 years) in 11 Ryan White Title III facilities in four states for information on eight standard-of-care recommendations during November 1996 through September 1997. Eligibility required a visit to the facility within 6 months before record abstraction and a lowest CD4+ lymphocyte count <500 cells/microl. Reviews were completed for 148 patients in Maryland, 355 in New York, 370 in Georgia, and 538 in Illinois. Adherence to prevention measures by health care providers was >85% for HIV plasma RNA testing, prescription of antiretroviral therapy, Pneumocystis carinii pneumonia (PCP) prophylaxis, anti-Toxoplasma antibody testing, and obtaining Papanicolaou (Pap) smears but lower (69%-80%) for Mycobacterium avium complex (MAC) prophylaxis, tuberculin skin testing (TST), and pneumococcal vaccination. Adherence was similar by patient age, gender, racial/ethnic group, urban versus rural, and hospital versus clinic setting but was generally lower for injecting drug users (IDUs) than for patients with other HIV exposures (p < .05 by multivariate analysis for TST, anti-Toxoplasma antibody testing, Pap smear, and measurement of HIV plasma RNA). Adherence by health care providers to guidelines for preventing OIs in these federally funded facilities is generally high but could be improved for some prevention measures, for instance, MAC prophylaxis, TST, and pneumococcal vaccination, especially for IDUs.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/prevenção & controle , Fármacos Anti-HIV/uso terapêutico , Fidelidade a Diretrizes/tendências , Instalações de Saúde , Programas Nacionais de Saúde , Guias de Prática Clínica como Assunto , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/imunologia , Infecções Oportunistas Relacionadas com a AIDS/virologia , Adolescente , Adulto , Animais , Anticorpos Antiprotozoários/sangue , Vacinas Bacterianas , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecção por Mycobacterium avium-intracellulare/prevenção & controle , Teste de Papanicolaou , Pneumonia Pneumocócica/prevenção & controle , Pneumonia por Pneumocystis/prevenção & controle , RNA Viral/sangue , Toxoplasma/imunologia , Teste Tuberculínico , Estados Unidos , Esfregaço Vaginal
3.
Am J Trop Med Hyg ; 56(4): 365-9, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9158041

RESUMO

The prevalence and importance of Cryptosporidium parvum as a causal agent of acute diarrhea among pediatric patients from Zulia State, Venezuela was assessed. Single stool specimens were collected from 310 children 0-60 months of age with acute diarrheal disease who were admitted to three public hospitals and from 150 comparable control children without gastrointestinal symptoms who were seen as outpatients. Cryptosporidium parvum oocysts were identified in 35 (11.2%) of 310 children with diarrhea and the coccidium was the single detectable pathogen in only 12 (34.2%). Other potential pathogenic parasites were present in most of the patients shedding oocysts (23 of 35, 65%). In nondiarrheal control children, oocysts were identified in nine (6%) of 150. The data suggest that C. parvum is relatively highly endemic in children 0-60 months of age in Zulia State and that although C. parvum may be an important pathogen associated with diarrhea, it may be a cause of only a small proportion of diarrheal episodes.


Assuntos
Criptosporidiose/epidemiologia , Cryptosporidium parvum , Diarreia Infantil/parasitologia , Diarreia/parasitologia , Doença Aguda , Distribuição por Idade , Animais , Pré-Escolar , Criptosporidiose/complicações , Cryptosporidium parvum/isolamento & purificação , Diarreia/complicações , Diarreia/epidemiologia , Diarreia Infantil/complicações , Diarreia Infantil/epidemiologia , Fezes/parasitologia , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Masculino , Distúrbios Nutricionais/epidemiologia , Distúrbios Nutricionais/etiologia , Prevalência , População Rural , População Urbana , Venezuela/epidemiologia
4.
Invest Clin ; 36(2): 83-93, 1995 Jun.
Artigo em Espanhol | MEDLINE | ID: mdl-7548303

RESUMO

The study was designed to know the effect of oral vitamin K (VK) treatment, on clotting factors II-VII-IX-X and the protein induced by VK absence from factor II (PIVCA II) on full term infants. Seventy healthy newborns were studied and each was randomly placed in one of two groups: Group A, newborns that received human milk and milk formula (mixed feeding)and group B, newborns that were exclusively breast fed. These groups were also divided in two subgroups: I received 2mg of VK1 orally and II (control) did not receive VK. Clotting activity of the coagulation factors and PIVCA II was determined from blood plasma obtained immediately after birth and 48 hours after VK administration. Basal activity of the factors analyzed was similar in all groups with values ranging from 25% to 40%. After 48 hours a significant increase in all factors studied and a decrease of PIVKA II was observed in those children who received oral VK. The results suggest that oral VK effectively increases VK dependent factors and prevents the risk of hemorrhagic disease in the newborn, with the advantage of being less traumatic and less risky to the infant than intramuscular VK.


Assuntos
Fator VII/análise , Fator X/análise , Protrombina/análise , Vitamina K/farmacologia , Humanos , Recém-Nascido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...